Repair Biotechnologies is developing a pipeline of therapies focused on regenerating the thymus, treating cancer, and reversing atherosclerosis. The company aims to improve human healthspan by addressing underlying causes of aging and age-related diseases. Founded in 2018 by Reason (CEO) and Bill Cherman (Chairman), the company is based in Syracuse, N.Y. Repair is advancing programs in preclinical development. In July 2019 it raised $2.15M in seed funding to accelerate that preclinical work. The financing is intended to support the company’s near-term R&D and development milestones.

Total raised

$2M

Funding rounds

1

Latest round

Seed

Latest activity

May 2019